News Daily News BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY Michael O'Riordan February 07, 2024
News Daily News Injectable Semaglutide Shortage Forces Physicians to Pivot Todd Neale February 05, 2024
News Daily News Universal Risk Tool Works Well in Both Primary and Secondary Prevention Michael O'Riordan February 01, 2024
News Daily News Short Bouts of Physical Activity May Offset Occupational Sitting CVD Risks L.A. McKeown January 24, 2024
News Daily News GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks Todd Neale January 21, 2024
News Daily News New Scientific Statement Focuses on Below-the-Knee Technical Challenges L.A. McKeown January 19, 2024
News Daily News No Fasting Before Cath? Study Shows No Harm—and Happier Patients L.A. McKeown January 16, 2024
News Daily News FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions Todd Neale January 12, 2024
News Daily News TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable Michael O'Riordan January 09, 2024
News Daily News No Signs of Hypoglycemia Causing CVD in CAROLINA and CARMELINA Michael O'Riordan January 05, 2024
News Daily News Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients L.A. McKeown January 02, 2024
News Daily News Who Benefits Most From Semaglutide and How Long Will That Take? Shelley Wood December 19, 2023
News Daily News Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk Todd Neale December 12, 2023
News Daily News Rethink Race in Pooled Cohort Equations for ASCVD, REGARDS Data Suggest L.A. McKeown December 11, 2023
News Daily News Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes Michael O'Riordan December 08, 2023
News Daily News No Safety Concerns Seen With Inclisiran in Large ORION Analysis Michael O'Riordan December 06, 2023